Review



nfat luciferase reporter jurkat cells  (BPS Bioscience)


Bioz Verified Symbol BPS Bioscience is a verified supplier
Bioz Manufacturer Symbol BPS Bioscience manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    BPS Bioscience nfat luciferase reporter jurkat cells
    Selective activation of SBT777101 <t>Jurkat</t> reporter cells by citrullinated proteins. Representative dose–response curves showing fold-increase in luminescence ( y -axis) relative to baseline following incubation with increasing concentrations (log scale, x -axis) of citrullinated (red) or noncitrullinated (black) protein targets. Data points represent the mean ± SD of 3 replicates.
    Nfat Luciferase Reporter Jurkat Cells, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 30 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nfat+luciferase+reporter/NFAT+Reporter+(Luc)+-+Jurkat+Recombinant+Cell+Line/pmc13637847-49-0-4
    Average 94 stars, based on 30 article reviews
    nfat luciferase reporter jurkat cells - by Bioz Stars, 2026-11
    94/100 stars

    Images

    1) Product Images from "Nonclinical safety assessment of SBT777101, a CAR-engineered regulatory T cell therapy for autoimmune diseases"

    Article Title: Nonclinical safety assessment of SBT777101, a CAR-engineered regulatory T cell therapy for autoimmune diseases

    Journal: Toxicological Sciences

    doi: 10.1093/toxsci/kfag125

    Selective activation of SBT777101 Jurkat reporter cells by citrullinated proteins. Representative dose–response curves showing fold-increase in luminescence ( y -axis) relative to baseline following incubation with increasing concentrations (log scale, x -axis) of citrullinated (red) or noncitrullinated (black) protein targets. Data points represent the mean ± SD of 3 replicates.
    Figure Legend Snippet: Selective activation of SBT777101 Jurkat reporter cells by citrullinated proteins. Representative dose–response curves showing fold-increase in luminescence ( y -axis) relative to baseline following incubation with increasing concentrations (log scale, x -axis) of citrullinated (red) or noncitrullinated (black) protein targets. Data points represent the mean ± SD of 3 replicates.

    Techniques Used: Activation Assay, Incubation

    Related Articles

    Cell Culture:

    Article Title: LILRB1-based chimeric antigen receptor
    Article Snippet: .. Cell Culture Jurkat cells encoding an NFAT luciferase reporter were obtained from BPS Bioscience. .. All other cell lines used in this study were obtained from ATCC.

    Article Title: Compositions and methods for treating HER2 positive cancers
    Article Snippet: .. Cell Culture Jurkat cells encoding an NFAT luciferase reporter were obtained from BPS Bioscience. ..

    Article Title: Compositions and methods for treating mesothelin positive cancers
    Article Snippet: .. Cell Culture Jurkat cells encoding an NFAT Luciferase reporter were obtained from BPS Bioscience. .. Cell Culture Jurkat cells encoding an NFAT Luciferase reporter were obtained from BPS Bioscience.

    Article Title: Compositions and methods for treating EGFR positive cancers
    Article Snippet: .. Cell Culture Jurkat cells encoding an NFAT Luciferase reporter were obtained from BPS Bioscience. .. Cell Culture Jurkat cells encoding an NFAT Luciferase reporter were obtained from BPS Bioscience.

    Article Title: Compositions and methods for treating CEACAM positive cancers
    Article Snippet: Cell Culture Jurkat cells encoding an NFAT Luciferase reporter were obtained from BPS Bioscience. .. Cell Culture Jurkat cells encoding an NFAT Luciferase reporter were obtained from BPS Bioscience. .. HeLa cells were maintained as suggested by ATCC.

    Luciferase:

    Article Title: LILRB1-based chimeric antigen receptor
    Article Snippet: .. Cell Culture Jurkat cells encoding an NFAT luciferase reporter were obtained from BPS Bioscience. .. All other cell lines used in this study were obtained from ATCC.

    Article Title: Compositions and methods for treating HER2 positive cancers
    Article Snippet: .. Cell Culture Jurkat cells encoding an NFAT luciferase reporter were obtained from BPS Bioscience. ..

    Article Title: Robust In Vitro Pharmacology of Tmod, a Synthetic Dual-Signal Integrator for Cancer Cell Therapy
    Article Snippet: .. The Jurkat cell line containing an NFAT luciferase reporter was obtained from BPS Bioscience. .. For MSLN Tmod and KRAS Tmod two-dimensional Ag titration, Jurkat cells were engineered by transduction with MSLN CAR + A*02 blocker lentivirus (custom lentivirus, Lentigen) and KRAS TCR lentivirus + A*02 blocker lentivirus (custom lentivirus, Alstem), respectively, at an MOI of 5, followed by enrichment using Anti-PE and/or Anti-APC MicroBeads (MACS Miltenyi Biotec).

    Article Title: Compositions and methods for treating mesothelin positive cancers
    Article Snippet: .. Cell Culture Jurkat cells encoding an NFAT Luciferase reporter were obtained from BPS Bioscience. .. Cell Culture Jurkat cells encoding an NFAT Luciferase reporter were obtained from BPS Bioscience.

    Article Title: Compositions and methods for treating EGFR positive cancers
    Article Snippet: .. Cell Culture Jurkat cells encoding an NFAT Luciferase reporter were obtained from BPS Bioscience. .. Cell Culture Jurkat cells encoding an NFAT Luciferase reporter were obtained from BPS Bioscience.

    Article Title: Compositions and methods for treating CEACAM positive cancers
    Article Snippet: Cell Culture Jurkat cells encoding an NFAT Luciferase reporter were obtained from BPS Bioscience. .. Cell Culture Jurkat cells encoding an NFAT Luciferase reporter were obtained from BPS Bioscience. .. HeLa cells were maintained as suggested by ATCC.

    Article Title: Compositions and methods for treating mesothelin positive cancers
    Article Snippet: .. Jurkat cells encoding an NFAT luciferase reporter were obtained from BPS Bioscience. .. Jurkat cells encoding an NFAT luciferase reporter were obtained from BPS Bioscience.



    Similar Products

    94
    BPS Bioscience nfat luciferase reporter jurkat cells
    Selective activation of SBT777101 <t>Jurkat</t> reporter cells by citrullinated proteins. Representative dose–response curves showing fold-increase in luminescence ( y -axis) relative to baseline following incubation with increasing concentrations (log scale, x -axis) of citrullinated (red) or noncitrullinated (black) protein targets. Data points represent the mean ± SD of 3 replicates.
    Nfat Luciferase Reporter Jurkat Cells, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nfat+luciferase+reporter/NFAT+Reporter+(Luc)+-+Jurkat+Recombinant+Cell+Line/pmc13637847-49-0-4
    Average 94 stars, based on 1 article reviews
    nfat luciferase reporter jurkat cells - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    Addgene inc nfat luciferase reporter
    (a) Schematic of native versus engineered GPCR trafficking (left). Native agonists typically induce GPCR internalization, followed by recycling or degradation. GTACs direct GPCRs for degradation by leveraging rapid, constitutive TfR1-mediated internalization. GTAC design (right): bifunctional antibody with GPCR-binding domain(s) and TfR1-binding domain(s) fused to an Fc. The control antibody lacks TfR1-binding domain(s). (b) Cell-surface GPCR levels (anti-FLAG flow cytometry) after treatment with GTACs or control antibodies. Cell-surface AT1R levels in FLAG-AT1R-GFP + TfR1 + Expi293 cells after 6 h treatment; cell-surface RXFP1 levels in FLAG-RXFP1 + TfR1 + Expi293 cells after 2 h treatment; cell-surface APJ levels in FLAG-APJ + TfR1 + HEK293T cells after 2 h treatment; and cell-surface A2AR levels in FLAG-A2AR + TfR1 + Expi293 cells after 6 h treatment. Data represent mean ± standard deviation (s.d.) from n = 3 replicates. (c) <t>NFAT-luciferase</t> activation in FLAG-AT1R + TfR1 + <t>NFAT-Luc</t> + Expi293 cells, after 2 h pre-treatment with 50 nM (left) or varying concentration (right) AT1R GTAC or Nb-Fc, followed by 4 h stimulation with varying concentration (left) or 9 nM (right) AngII. Data represent mean ± s.d. from n = 4 biological replicates. (d) β-arrestin recruitment in FLAG-AT1R-Tango + TfR1 + HTLA cells (luminescence) after pre-treatment for 2 h with 50 nM (left) or varying concentration (right) AT1R GTAC or Nb-Fc, followed by 14 h activation with varying concentrations (left) or 200 nM (right) AngII. Data represent mean ± s.d. from n = 3 biological replicates for both experiments. (e) RLN2-induced cAMP signaling in FLAG-RXFP1 + TfR1 + GloSensor + HEK293T cells (luminescence) after 2 h pre-treatment with 10 nM (left) or varying concentration (right) RXFP1 GTAC or control, followed by 30 min stimulation with RLN2 at varying concentrations (left) or 1 nM (right). Data represent mean ± s.d. from n = 3 biological replicates.
    Nfat Luciferase Reporter, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nfat+luciferase+reporter/NFAT+luciferase+reporter+(Plasmid+%2310959)/pmc13632652-465-0-9
    Average 93 stars, based on 1 article reviews
    nfat luciferase reporter - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    95
    InvivoGen jurkat cells nfat dependent luciferase reporter assay
    (a) Schematic of native versus engineered GPCR trafficking (left). Native agonists typically induce GPCR internalization, followed by recycling or degradation. GTACs direct GPCRs for degradation by leveraging rapid, constitutive TfR1-mediated internalization. GTAC design (right): bifunctional antibody with GPCR-binding domain(s) and TfR1-binding domain(s) fused to an Fc. The control antibody lacks TfR1-binding domain(s). (b) Cell-surface GPCR levels (anti-FLAG flow cytometry) after treatment with GTACs or control antibodies. Cell-surface AT1R levels in FLAG-AT1R-GFP + TfR1 + Expi293 cells after 6 h treatment; cell-surface RXFP1 levels in FLAG-RXFP1 + TfR1 + Expi293 cells after 2 h treatment; cell-surface APJ levels in FLAG-APJ + TfR1 + HEK293T cells after 2 h treatment; and cell-surface A2AR levels in FLAG-A2AR + TfR1 + Expi293 cells after 6 h treatment. Data represent mean ± standard deviation (s.d.) from n = 3 replicates. (c) <t>NFAT-luciferase</t> activation in FLAG-AT1R + TfR1 + <t>NFAT-Luc</t> + Expi293 cells, after 2 h pre-treatment with 50 nM (left) or varying concentration (right) AT1R GTAC or Nb-Fc, followed by 4 h stimulation with varying concentration (left) or 9 nM (right) AngII. Data represent mean ± s.d. from n = 4 biological replicates. (d) β-arrestin recruitment in FLAG-AT1R-Tango + TfR1 + HTLA cells (luminescence) after pre-treatment for 2 h with 50 nM (left) or varying concentration (right) AT1R GTAC or Nb-Fc, followed by 14 h activation with varying concentrations (left) or 200 nM (right) AngII. Data represent mean ± s.d. from n = 3 biological replicates for both experiments. (e) RLN2-induced cAMP signaling in FLAG-RXFP1 + TfR1 + GloSensor + HEK293T cells (luminescence) after 2 h pre-treatment with 10 nM (left) or varying concentration (right) RXFP1 GTAC or control, followed by 30 min stimulation with RLN2 at varying concentrations (left) or 1 nM (right). Data represent mean ± s.d. from n = 3 biological replicates.
    Jurkat Cells Nfat Dependent Luciferase Reporter Assay, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nfat+luciferase+reporter/Jurkat-Lucia+NFAT+Cells/pm41974720-439-5-20
    Average 95 stars, based on 1 article reviews
    jurkat cells nfat dependent luciferase reporter assay - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    94
    BPS Bioscience cd8 tcr knockout nfat luciferase reporter jurkat cell line
    (a) Schematic of native versus engineered GPCR trafficking (left). Native agonists typically induce GPCR internalization, followed by recycling or degradation. GTACs direct GPCRs for degradation by leveraging rapid, constitutive TfR1-mediated internalization. GTAC design (right): bifunctional antibody with GPCR-binding domain(s) and TfR1-binding domain(s) fused to an Fc. The control antibody lacks TfR1-binding domain(s). (b) Cell-surface GPCR levels (anti-FLAG flow cytometry) after treatment with GTACs or control antibodies. Cell-surface AT1R levels in FLAG-AT1R-GFP + TfR1 + Expi293 cells after 6 h treatment; cell-surface RXFP1 levels in FLAG-RXFP1 + TfR1 + Expi293 cells after 2 h treatment; cell-surface APJ levels in FLAG-APJ + TfR1 + HEK293T cells after 2 h treatment; and cell-surface A2AR levels in FLAG-A2AR + TfR1 + Expi293 cells after 6 h treatment. Data represent mean ± standard deviation (s.d.) from n = 3 replicates. (c) <t>NFAT-luciferase</t> activation in FLAG-AT1R + TfR1 + <t>NFAT-Luc</t> + Expi293 cells, after 2 h pre-treatment with 50 nM (left) or varying concentration (right) AT1R GTAC or Nb-Fc, followed by 4 h stimulation with varying concentration (left) or 9 nM (right) AngII. Data represent mean ± s.d. from n = 4 biological replicates. (d) β-arrestin recruitment in FLAG-AT1R-Tango + TfR1 + HTLA cells (luminescence) after pre-treatment for 2 h with 50 nM (left) or varying concentration (right) AT1R GTAC or Nb-Fc, followed by 14 h activation with varying concentrations (left) or 200 nM (right) AngII. Data represent mean ± s.d. from n = 3 biological replicates for both experiments. (e) RLN2-induced cAMP signaling in FLAG-RXFP1 + TfR1 + GloSensor + HEK293T cells (luminescence) after 2 h pre-treatment with 10 nM (left) or varying concentration (right) RXFP1 GTAC or control, followed by 30 min stimulation with RLN2 at varying concentrations (left) or 1 nM (right). Data represent mean ± s.d. from n = 3 biological replicates.
    Cd8 Tcr Knockout Nfat Luciferase Reporter Jurkat Cell Line, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nfat+luciferase+reporter/TCR+Knockout+NFAT-Luciferase+Reporter+Jurkat+Cell+Line/10__1158_slash_2326___6066__cir___25___1016-105-7-20
    Average 94 stars, based on 1 article reviews
    cd8 tcr knockout nfat luciferase reporter jurkat cell line - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    ATCC nfat luciferase reporter assay mouse t lymphoblast cell line bw5147 g 1 4
    (a) Schematic of native versus engineered GPCR trafficking (left). Native agonists typically induce GPCR internalization, followed by recycling or degradation. GTACs direct GPCRs for degradation by leveraging rapid, constitutive TfR1-mediated internalization. GTAC design (right): bifunctional antibody with GPCR-binding domain(s) and TfR1-binding domain(s) fused to an Fc. The control antibody lacks TfR1-binding domain(s). (b) Cell-surface GPCR levels (anti-FLAG flow cytometry) after treatment with GTACs or control antibodies. Cell-surface AT1R levels in FLAG-AT1R-GFP + TfR1 + Expi293 cells after 6 h treatment; cell-surface RXFP1 levels in FLAG-RXFP1 + TfR1 + Expi293 cells after 2 h treatment; cell-surface APJ levels in FLAG-APJ + TfR1 + HEK293T cells after 2 h treatment; and cell-surface A2AR levels in FLAG-A2AR + TfR1 + Expi293 cells after 6 h treatment. Data represent mean ± standard deviation (s.d.) from n = 3 replicates. (c) <t>NFAT-luciferase</t> activation in FLAG-AT1R + TfR1 + <t>NFAT-Luc</t> + Expi293 cells, after 2 h pre-treatment with 50 nM (left) or varying concentration (right) AT1R GTAC or Nb-Fc, followed by 4 h stimulation with varying concentration (left) or 9 nM (right) AngII. Data represent mean ± s.d. from n = 4 biological replicates. (d) β-arrestin recruitment in FLAG-AT1R-Tango + TfR1 + HTLA cells (luminescence) after pre-treatment for 2 h with 50 nM (left) or varying concentration (right) AT1R GTAC or Nb-Fc, followed by 14 h activation with varying concentrations (left) or 200 nM (right) AngII. Data represent mean ± s.d. from n = 3 biological replicates for both experiments. (e) RLN2-induced cAMP signaling in FLAG-RXFP1 + TfR1 + GloSensor + HEK293T cells (luminescence) after 2 h pre-treatment with 10 nM (left) or varying concentration (right) RXFP1 GTAC or control, followed by 30 min stimulation with RLN2 at varying concentrations (left) or 1 nM (right). Data represent mean ± s.d. from n = 3 biological replicates.
    Nfat Luciferase Reporter Assay Mouse T Lymphoblast Cell Line Bw5147 G 1 4, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nfat+luciferase+reporter/BW5147%2EG%2E1%2E4/us12545729-234-3-12
    Average 94 stars, based on 1 article reviews
    nfat luciferase reporter assay mouse t lymphoblast cell line bw5147 g 1 4 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    BPS Bioscience cd8 tcr knockout nfat luciferase reporter jurkat cells
    (a) Schematic of native versus engineered GPCR trafficking (left). Native agonists typically induce GPCR internalization, followed by recycling or degradation. GTACs direct GPCRs for degradation by leveraging rapid, constitutive TfR1-mediated internalization. GTAC design (right): bifunctional antibody with GPCR-binding domain(s) and TfR1-binding domain(s) fused to an Fc. The control antibody lacks TfR1-binding domain(s). (b) Cell-surface GPCR levels (anti-FLAG flow cytometry) after treatment with GTACs or control antibodies. Cell-surface AT1R levels in FLAG-AT1R-GFP + TfR1 + Expi293 cells after 6 h treatment; cell-surface RXFP1 levels in FLAG-RXFP1 + TfR1 + Expi293 cells after 2 h treatment; cell-surface APJ levels in FLAG-APJ + TfR1 + HEK293T cells after 2 h treatment; and cell-surface A2AR levels in FLAG-A2AR + TfR1 + Expi293 cells after 6 h treatment. Data represent mean ± standard deviation (s.d.) from n = 3 replicates. (c) <t>NFAT-luciferase</t> activation in FLAG-AT1R + TfR1 + <t>NFAT-Luc</t> + Expi293 cells, after 2 h pre-treatment with 50 nM (left) or varying concentration (right) AT1R GTAC or Nb-Fc, followed by 4 h stimulation with varying concentration (left) or 9 nM (right) AngII. Data represent mean ± s.d. from n = 4 biological replicates. (d) β-arrestin recruitment in FLAG-AT1R-Tango + TfR1 + HTLA cells (luminescence) after pre-treatment for 2 h with 50 nM (left) or varying concentration (right) AT1R GTAC or Nb-Fc, followed by 14 h activation with varying concentrations (left) or 200 nM (right) AngII. Data represent mean ± s.d. from n = 3 biological replicates for both experiments. (e) RLN2-induced cAMP signaling in FLAG-RXFP1 + TfR1 + GloSensor + HEK293T cells (luminescence) after 2 h pre-treatment with 10 nM (left) or varying concentration (right) RXFP1 GTAC or control, followed by 30 min stimulation with RLN2 at varying concentrations (left) or 1 nM (right). Data represent mean ± s.d. from n = 3 biological replicates.
    Cd8 Tcr Knockout Nfat Luciferase Reporter Jurkat Cells, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nfat+luciferase+reporter/TCR+Knockout+NFAT-Luciferase+Reporter+Jurkat+Cell+Line/bio_rxiv__64898__2026__02__04__703820-272-0-7
    Average 94 stars, based on 1 article reviews
    cd8 tcr knockout nfat luciferase reporter jurkat cells - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    BPS Bioscience lentiviral nfat luciferase egfp reporter construct
    Establishment of reporter T cells and CRISPR/Cas9-mediated knock-in of a candidate T cell receptor (TCR). ( A ) Surface marker expression of parental Jurkat E6-1 cells. Histograms show the expression levels of the indicated markers. ( B ) Surface marker expression of engineered reporter T cells. Histograms show the expression levels of the indicated markers. ( C ) Schematic overview of the genetic modifications performed to generate reporter T cells. Parental Jurkat E6-1 cells were subjected to CRISPR/Cas9-mediated knockout of CD4, FAS, and TCRα, and <t>lentiviral</t> transduction of CD8α, CD8β, Cas9, and the NFAT–Luc–P2A–eGFP reporter cassette. ( D ) Targeted reconstitution of the TCR in reporter T cells at the endogenous TCRβ locus. ( E ) Flow cytometric analysis of CD3 restoration in reporter T cells after targeted reconstitution with the NY-ESO-1–specific 1G4 TCR. CD3 + cells were sorted to generate a uniform population of TCR-expressing reporter T cells. Pseudocolor plots indicate event density (blue, lower; red, higher).
    Lentiviral Nfat Luciferase Egfp Reporter Construct, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nfat+luciferase+reporter/NFAT+Luciferase-eGFP+Reporter+Lentivirus/pmc12650950-74-7-13
    Average 94 stars, based on 1 article reviews
    lentiviral nfat luciferase egfp reporter construct - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    BPS Bioscience t cells jurkat t cells
    Establishment of reporter T cells and CRISPR/Cas9-mediated knock-in of a candidate T cell receptor (TCR). ( A ) Surface marker expression of parental Jurkat E6-1 cells. Histograms show the expression levels of the indicated markers. ( B ) Surface marker expression of engineered reporter T cells. Histograms show the expression levels of the indicated markers. ( C ) Schematic overview of the genetic modifications performed to generate reporter T cells. Parental Jurkat E6-1 cells were subjected to CRISPR/Cas9-mediated knockout of CD4, FAS, and TCRα, and <t>lentiviral</t> transduction of CD8α, CD8β, Cas9, and the NFAT–Luc–P2A–eGFP reporter cassette. ( D ) Targeted reconstitution of the TCR in reporter T cells at the endogenous TCRβ locus. ( E ) Flow cytometric analysis of CD3 restoration in reporter T cells after targeted reconstitution with the NY-ESO-1–specific 1G4 TCR. CD3 + cells were sorted to generate a uniform population of TCR-expressing reporter T cells. Pseudocolor plots indicate event density (blue, lower; red, higher).
    T Cells Jurkat T Cells, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nfat+luciferase+reporter/NFAT+Luciferase-eGFP+Reporter+Jurkat+Cell+Line/us12466886-416-46-58
    Average 94 stars, based on 1 article reviews
    t cells jurkat t cells - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    BPS Bioscience nfat re reporter gene
    Establishment of reporter T cells and CRISPR/Cas9-mediated knock-in of a candidate T cell receptor (TCR). ( A ) Surface marker expression of parental Jurkat E6-1 cells. Histograms show the expression levels of the indicated markers. ( B ) Surface marker expression of engineered reporter T cells. Histograms show the expression levels of the indicated markers. ( C ) Schematic overview of the genetic modifications performed to generate reporter T cells. Parental Jurkat E6-1 cells were subjected to CRISPR/Cas9-mediated knockout of CD4, FAS, and TCRα, and <t>lentiviral</t> transduction of CD8α, CD8β, Cas9, and the NFAT–Luc–P2A–eGFP reporter cassette. ( D ) Targeted reconstitution of the TCR in reporter T cells at the endogenous TCRβ locus. ( E ) Flow cytometric analysis of CD3 restoration in reporter T cells after targeted reconstitution with the NY-ESO-1–specific 1G4 TCR. CD3 + cells were sorted to generate a uniform population of TCR-expressing reporter T cells. Pseudocolor plots indicate event density (blue, lower; red, higher).
    Nfat Re Reporter Gene, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nfat+luciferase+reporter/NFAT+Reporter+(Luciferase)+-+THP-1+Cell+Line/us12466886-416-52-58
    Average 94 stars, based on 1 article reviews
    nfat re reporter gene - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    BPS Bioscience jurkat cells
    Establishment of reporter T cells and CRISPR/Cas9-mediated knock-in of a candidate T cell receptor (TCR). ( A ) Surface marker expression of parental Jurkat E6-1 cells. Histograms show the expression levels of the indicated markers. ( B ) Surface marker expression of engineered reporter T cells. Histograms show the expression levels of the indicated markers. ( C ) Schematic overview of the genetic modifications performed to generate reporter T cells. Parental Jurkat E6-1 cells were subjected to CRISPR/Cas9-mediated knockout of CD4, FAS, and TCRα, and <t>lentiviral</t> transduction of CD8α, CD8β, Cas9, and the NFAT–Luc–P2A–eGFP reporter cassette. ( D ) Targeted reconstitution of the TCR in reporter T cells at the endogenous TCRβ locus. ( E ) Flow cytometric analysis of CD3 restoration in reporter T cells after targeted reconstitution with the NY-ESO-1–specific 1G4 TCR. CD3 + cells were sorted to generate a uniform population of TCR-expressing reporter T cells. Pseudocolor plots indicate event density (blue, lower; red, higher).
    Jurkat Cells, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nfat+luciferase+reporter/NFAT+Luciferase-eGFP+Reporter+Jurkat+Cell+Line/pm41176533-252-5-15
    Average 94 stars, based on 1 article reviews
    jurkat cells - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    Selective activation of SBT777101 Jurkat reporter cells by citrullinated proteins. Representative dose–response curves showing fold-increase in luminescence ( y -axis) relative to baseline following incubation with increasing concentrations (log scale, x -axis) of citrullinated (red) or noncitrullinated (black) protein targets. Data points represent the mean ± SD of 3 replicates.

    Journal: Toxicological Sciences

    Article Title: Nonclinical safety assessment of SBT777101, a CAR-engineered regulatory T cell therapy for autoimmune diseases

    doi: 10.1093/toxsci/kfag125

    Figure Lengend Snippet: Selective activation of SBT777101 Jurkat reporter cells by citrullinated proteins. Representative dose–response curves showing fold-increase in luminescence ( y -axis) relative to baseline following incubation with increasing concentrations (log scale, x -axis) of citrullinated (red) or noncitrullinated (black) protein targets. Data points represent the mean ± SD of 3 replicates.

    Article Snippet: NFAT-luciferase reporter Jurkat cells (BPS Bioscience) were stably transduced with the SBT777101 CAR.

    Techniques: Activation Assay, Incubation

    (a) Schematic of native versus engineered GPCR trafficking (left). Native agonists typically induce GPCR internalization, followed by recycling or degradation. GTACs direct GPCRs for degradation by leveraging rapid, constitutive TfR1-mediated internalization. GTAC design (right): bifunctional antibody with GPCR-binding domain(s) and TfR1-binding domain(s) fused to an Fc. The control antibody lacks TfR1-binding domain(s). (b) Cell-surface GPCR levels (anti-FLAG flow cytometry) after treatment with GTACs or control antibodies. Cell-surface AT1R levels in FLAG-AT1R-GFP + TfR1 + Expi293 cells after 6 h treatment; cell-surface RXFP1 levels in FLAG-RXFP1 + TfR1 + Expi293 cells after 2 h treatment; cell-surface APJ levels in FLAG-APJ + TfR1 + HEK293T cells after 2 h treatment; and cell-surface A2AR levels in FLAG-A2AR + TfR1 + Expi293 cells after 6 h treatment. Data represent mean ± standard deviation (s.d.) from n = 3 replicates. (c) NFAT-luciferase activation in FLAG-AT1R + TfR1 + NFAT-Luc + Expi293 cells, after 2 h pre-treatment with 50 nM (left) or varying concentration (right) AT1R GTAC or Nb-Fc, followed by 4 h stimulation with varying concentration (left) or 9 nM (right) AngII. Data represent mean ± s.d. from n = 4 biological replicates. (d) β-arrestin recruitment in FLAG-AT1R-Tango + TfR1 + HTLA cells (luminescence) after pre-treatment for 2 h with 50 nM (left) or varying concentration (right) AT1R GTAC or Nb-Fc, followed by 14 h activation with varying concentrations (left) or 200 nM (right) AngII. Data represent mean ± s.d. from n = 3 biological replicates for both experiments. (e) RLN2-induced cAMP signaling in FLAG-RXFP1 + TfR1 + GloSensor + HEK293T cells (luminescence) after 2 h pre-treatment with 10 nM (left) or varying concentration (right) RXFP1 GTAC or control, followed by 30 min stimulation with RLN2 at varying concentrations (left) or 1 nM (right). Data represent mean ± s.d. from n = 3 biological replicates.

    Journal: Nature

    Article Title: GPCR antagonism via rewiring of receptor trafficking and degradation

    doi: 10.1038/s41586-026-11088-0

    Figure Lengend Snippet: (a) Schematic of native versus engineered GPCR trafficking (left). Native agonists typically induce GPCR internalization, followed by recycling or degradation. GTACs direct GPCRs for degradation by leveraging rapid, constitutive TfR1-mediated internalization. GTAC design (right): bifunctional antibody with GPCR-binding domain(s) and TfR1-binding domain(s) fused to an Fc. The control antibody lacks TfR1-binding domain(s). (b) Cell-surface GPCR levels (anti-FLAG flow cytometry) after treatment with GTACs or control antibodies. Cell-surface AT1R levels in FLAG-AT1R-GFP + TfR1 + Expi293 cells after 6 h treatment; cell-surface RXFP1 levels in FLAG-RXFP1 + TfR1 + Expi293 cells after 2 h treatment; cell-surface APJ levels in FLAG-APJ + TfR1 + HEK293T cells after 2 h treatment; and cell-surface A2AR levels in FLAG-A2AR + TfR1 + Expi293 cells after 6 h treatment. Data represent mean ± standard deviation (s.d.) from n = 3 replicates. (c) NFAT-luciferase activation in FLAG-AT1R + TfR1 + NFAT-Luc + Expi293 cells, after 2 h pre-treatment with 50 nM (left) or varying concentration (right) AT1R GTAC or Nb-Fc, followed by 4 h stimulation with varying concentration (left) or 9 nM (right) AngII. Data represent mean ± s.d. from n = 4 biological replicates. (d) β-arrestin recruitment in FLAG-AT1R-Tango + TfR1 + HTLA cells (luminescence) after pre-treatment for 2 h with 50 nM (left) or varying concentration (right) AT1R GTAC or Nb-Fc, followed by 14 h activation with varying concentrations (left) or 200 nM (right) AngII. Data represent mean ± s.d. from n = 3 biological replicates for both experiments. (e) RLN2-induced cAMP signaling in FLAG-RXFP1 + TfR1 + GloSensor + HEK293T cells (luminescence) after 2 h pre-treatment with 10 nM (left) or varying concentration (right) RXFP1 GTAC or control, followed by 30 min stimulation with RLN2 at varying concentrations (left) or 1 nM (right). Data represent mean ± s.d. from n = 3 biological replicates.

    Article Snippet: NFAT luciferase reporter was a gift from Toren Finkel (Addgene plasmid #10959; http://n2t.net/addgene:10959 ; RRID:Addgene_10959).

    Techniques: Binding Assay, Control, Flow Cytometry, Standard Deviation, Luciferase, Activation Assay, Concentration Assay

    Establishment of reporter T cells and CRISPR/Cas9-mediated knock-in of a candidate T cell receptor (TCR). ( A ) Surface marker expression of parental Jurkat E6-1 cells. Histograms show the expression levels of the indicated markers. ( B ) Surface marker expression of engineered reporter T cells. Histograms show the expression levels of the indicated markers. ( C ) Schematic overview of the genetic modifications performed to generate reporter T cells. Parental Jurkat E6-1 cells were subjected to CRISPR/Cas9-mediated knockout of CD4, FAS, and TCRα, and lentiviral transduction of CD8α, CD8β, Cas9, and the NFAT–Luc–P2A–eGFP reporter cassette. ( D ) Targeted reconstitution of the TCR in reporter T cells at the endogenous TCRβ locus. ( E ) Flow cytometric analysis of CD3 restoration in reporter T cells after targeted reconstitution with the NY-ESO-1–specific 1G4 TCR. CD3 + cells were sorted to generate a uniform population of TCR-expressing reporter T cells. Pseudocolor plots indicate event density (blue, lower; red, higher).

    Journal: Cells

    Article Title: NeoPAIR-T: Functional Mapping of Neoantigen–TCR Pairs Using a CRISPR-Engineered Jurkat Reporter System

    doi: 10.3390/cells14221789

    Figure Lengend Snippet: Establishment of reporter T cells and CRISPR/Cas9-mediated knock-in of a candidate T cell receptor (TCR). ( A ) Surface marker expression of parental Jurkat E6-1 cells. Histograms show the expression levels of the indicated markers. ( B ) Surface marker expression of engineered reporter T cells. Histograms show the expression levels of the indicated markers. ( C ) Schematic overview of the genetic modifications performed to generate reporter T cells. Parental Jurkat E6-1 cells were subjected to CRISPR/Cas9-mediated knockout of CD4, FAS, and TCRα, and lentiviral transduction of CD8α, CD8β, Cas9, and the NFAT–Luc–P2A–eGFP reporter cassette. ( D ) Targeted reconstitution of the TCR in reporter T cells at the endogenous TCRβ locus. ( E ) Flow cytometric analysis of CD3 restoration in reporter T cells after targeted reconstitution with the NY-ESO-1–specific 1G4 TCR. CD3 + cells were sorted to generate a uniform population of TCR-expressing reporter T cells. Pseudocolor plots indicate event density (blue, lower; red, higher).

    Article Snippet: Finally, these cells were transduced with a lentiviral NFAT-Luciferase-eGFP reporter construct ( , BPS Bioscience, San Diego, CA, USA) at MOI of 20 and selected with 2 mg/mL G418 (FujiFilm Wako Pure Chemical Corporation).

    Techniques: CRISPR, Knock-In, Marker, Expressing, Knock-Out, Transduction